RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics to Participate in Upcoming Investor Conferences

11 апр 2024 15:05:14 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

26 фев 2024 15:05:17 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

22 фев 2024 15:05:19 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

15 фев 2024 15:05:27 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 фев 2024 15:05:05 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces $30 Million Private Placement Financing

08 янв 2024 06:00:32 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 янв 2024 15:05:12 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

07 ноя 2023 15:05:18 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights

02 ноя 2023 15:05:42 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023

26 окт 2023 15:05:51 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors

12 окт 2023 15:05:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

18 сен 2023 15:05:42 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights

08 авг 2023 15:02:09 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023

01 авг 2023 15:05:24 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008

25 май 2023 16:01:31 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

24 май 2023 15:05:03 Источник Nasdaq GlobeNewswire

Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights

04 май 2023 15:05:47 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights

27 апр 2023 15:05:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

19 апр 2023 06:30:00 Источник Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations

18 апр 2023 09:40:00 Источник Nasdaq GlobeNewswire